Amneal Pharmaceuticals Inc expected to post earnings of 18 cents a share - Earnings Preview

Amneal Pharmaceuticals

01/08/2025 14:56

Amneal Pharmaceuticals Inc AMRX.OQ AMRX.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2025

The Bridgewater New Jersey-based  company is expected to report a 6.1% increase in revenue to $744.561 million from $701.78 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Amneal Pharmaceuticals Inc is for earnings of 18 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Amneal Pharmaceuticals Inc is $12.00, about 34.8% above its last closing price of $7.82

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.14
0.15
0.21
Beat
43.2
Dec. 31 2025
0.15
0.15
0.12
Missed
-21.3
Sep. 30 2024
0.13
0.14
0.16
Beat
18.5​
Jun. 30 2024
0.13
0.14
0.16
Beat
15.5
​​Mar. 31 2024
0.09
0.09
0.14
Beat
52.2
Dec. 31 2023
0.09
0.09
0.14
Beat
55.2​
Sep. 30 2023
0.16
0.13
0.19
Beat
49.8
Jun. 30 2023
0.11
0.11
0.19
Beat
79.2

This summary was machine generated August 1 at 13:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)